Q2 2026 Earnings
Financial report interval: 2026.03.30 - 2026.06.30
Overview: BETTA PHARMACEUTICALS(300558) the Revenue is 936.09 M (+15.02%), Miss estimate;the EBIT is 86.22 M (+25.49%), Miss estimate;the EPS is 0.15 (+66.67%), Beat estimate.
Actual
YoY
Estimate
YoY
Vs estimate
YoY
RevenueMiss expectations
0.94B15.02%
1.02B25.21%
-0.08B10.19%
EBITMiss expectations
0.09B25.49%
0.13B90.62%
-0.04B65.13%
EPSExceed expectations
0.1566.67%
0.1233.33%
+0.030033.34%
Revenue
ActualEstimateUnit: CNY
qf
EBIT
ActualEstimateUnit: CNY
qf
Net income
ActualEstimateUnit: CNY
qf
EPS
ActualEstimateUnit: CNY
qf